Clinical Trial Update: Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis [Phase 1]

View source ↗

Summary

A Phase 1 mass balance study evaluating JTZ-951 in subjects with end-stage renal disease on hemodialysis has been completed, in the context of anemia of chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• JTZ-951

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Anemia of Chronic Kidney Disease | Phase 1 | Status: COMPLETED